New Delhi: A Parliamentary Standing Committee has described the government’s peak health spending of 1.84 per cent of GDP in 2021-22 as an “anomaly” created by one‑off COVID relief and vaccination outlays, and has urged the Centre to adopt a statutory, ring‑fenced, multi‑year funding roadmap to reach the National Health Policy target of 2.5 per cent of GDP.
Committee says pandemic-year figure misleads on progress
The committee on Health and Family Welfare, chaired by Samajwadi Party leader Ram Gopal Yadav, said the surge in Government Health Expenditure (GHE) in 2021-22 gave a misleading impression of sustained progress. The panel pointed to revised estimates for 2022-23 that show a sharp reversion to 1.43 per cent of GDP, underlining that the 2021-22 number was driven by exceptional public health needs during the pandemic.
According to the report on ‘Affordability and Accessibility of Healthcare Facilities in Private and Public Sector’, the apparent improvement was a distortion that corrected when delayed accounting for 2022-23 was published. The committee noted that GHE as a share of General Government Expenditure (GGE) fell from a peak of 6.12 per cent in 2021-22 to 4.89 per cent in 2022-23, a level lower than the pre‑pandemic baseline of 5.02 per cent in 2019-20.
"This glide path must be secured by ring‑fenced, multi‑year budgetary commitments rather than single‑year allocations that are vulnerable to cutbacks," the report said.
What the committee wants
The Standing Committee has asked the Ministry of Health and Family Welfare, in consultation with the Ministry of Finance, to prepare a year‑wise, costed glide path detailing how GHE will move from current levels to 2.5 per cent of GDP. The committee emphasised that the target must move beyond aspiration and be backed by binding timelines and protected budget lines.
- Prepare a costed, year‑wise roadmap to reach 2.5% of GDP GHE.
- Introduce statutory minimum thresholds for health allocations as a proportion of total government expenditure.
- Secure multi‑year, ring‑fenced funding to insulate health budgets from emergency fiscal cycles and post‑pandemic reversions.
The committee expressed concern that treating health allocations as expendable once an emergency subsides "fundamentally undermines the structural integrity and resilience of the healthcare system", and called for annual progress reporting to Parliament.
Context and consequences: what it means for fiscal policy and citizens
The panel’s recommendations have direct implications for Union budget framing and medium‑term fiscal strategy. Ring‑fenced, statutory commitments would limit the fiscal flexibility governments normally exercise during economic slowdowns or competing spending priorities. For citizens, the committee argues, predictable funding could strengthen public health infrastructure, improve access and affordability of services, and reduce dependence on out‑of‑pocket spending.
At present, GHE remains well short of the National Health Policy target. The committee is effectively asking the government to convert the target into a binding fiscal trajectory with clear annual milestones and protected allocations to prevent recurring slippage.
| Year | GHE (% of GDP) | GHE as % of GGE |
|---|---|---|
| 2019-20 | — | 5.02% |
| 2021-22 (pandemic year) | 1.84% | 6.12% |
| 2022-23 (revised) | 1.43% | 4.89% |
Note: The report highlighted that the 2021-22 spike was mainly due to COVID‑related expenditure including vaccination drives and emergency relief, rather than sustained increases in baseline health provisioning.
Implementing statutory minimums would require legal or budgetary instrument design, and closer coordination between the health and finance ministries. It would also likely involve trade‑offs in the fiscal framework, particularly if the Centre opts for legally protected health allocations without corresponding revenue enhancements.
The committee’s call for annual reporting to Parliament aims to build transparency and accountability so that progress or slippage on the glide path is visible to legislators and the public.
For households, the committee’s stance reinforces the argument for strengthening public financing to reduce catastrophic health spending. For investors and markets, greater clarity on long‑term government commitment to health could alter expectations for related sectors — including pharmaceuticals, diagnostics and private healthcare providers — but the report does not offer specific policy prescriptions beyond funding architecture.
The Standing Committee’s report has been submitted to Parliament and will form part of wider deliberations on health sector financing ahead of future budgets.
